Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLEO DIAGNOSTICS LTD Major Shareholding Notification 2026

Jan 4, 2026

64689_rns_2026-01-04_421d71b6-9001-4a75-b70e-3cda06a64e4d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

605[page1/2][15July2018]

Form 605

Corporations Act 2001 Section 671B

Notice of ceasing to be a substantial holder

To Company/registered scheme/notified foreign passport fund name CLEO DIAGNOSTICS LIMITED ACN/ARSN/APFRN 655 717 169 NFPFRN (if applicable) Not Applicable

1. Details of substantial holder (1)

Name HUDSON INSTITUTE INVESTMENT HOLDINGS PTY LTD ACN/ARSN/APFRN (if applicable) 641 773 159 NFPFRN (if applicable) Not Applicable

The holder ceased to be a substantial holder on 29 / 12 / 2025 The previous notice was given to the company, or the responsible entity for a registered scheme, or the operator of a notified foreign passport fund on / / The previous notice was dated / /

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company, scheme or fund, since the substantial holder was last required to give a substantial holding notice to the company, scheme or fund are as follows:

see attached Annexure A

Date of
change
Person whose relevant
interest changed
Nature of
change(4)
Consideration given
in relation to
change (5)
Class (6) and
number of
securities
affected

Person's votes
affected

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting securities in the company, scheme or fund are as follows:

Name and ACN/ARSN/APFRN (if applicable)
and NFPFRN (if applicable)
Nature of association

4. Addresses

The addresses of persons named in this form are as follows:

Name Address
ROBERT MERRIEL 3 EVERTON GROVE,SURREY HILLS,VIC,3127

Signature

print name

ROBERT MERRIEL

capacity DIRECTOR

==> picture [48 x 33] intentionally omitted <==

sign here

date / 05/01/2026 /

605[page 2/2 15July 2018 ]

DIRECTIONS

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.

  • (2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (3) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (4) Include details of:

  • (a) Any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (5) Details of the consideration must include any and all benefits, money or otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (6) The voting shares of accompany constitute one class unless divided into separate classes.

  • (7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

ANNEXURE A

Detail for Form 605 HUDSON INSTITUTE INVESTMENT HOLDINGS PTY LTD - ACN 641 773 159

**Date of Change ** Person whose relevant interest changed Nature of Change Consideration Consideration Class of Securities Number of
Shares
Person's votes affected
1/07/2025 Hudson Institute Investment Holdings On Market sale $ 155.12
Ordinary fully paid shares 383 Hudson Institute Investment Holdings
1/07/2025 Hudson Institute Investment Holdings On Market sale $ 6,300.00
Ordinary fully paid shares 15,000 Hudson Institute Investment Holdings
1/07/2025 Hudson Institute Investment Holdings On Market sale $ 7,387.41
Ordinary fully paid shares 17,485 Hudson Institute Investment Holdings
2/07/2025 Hudson Institute Investment Holdings On Market sale $ 1,861.60
Ordinary fully paid shares 4,654 Hudson Institute Investment Holdings
4/07/2025 Hudson Institute Investment Holdings On Market sale $ 20,545.60
Ordinary fully paid shares 51,364 Hudson Institute Investment Holdings
4/07/2025 Hudson Institute Investment Holdings On Market sale $ 658.09
Ordinary fully paid shares 1,635 Hudson Institute Investment Holdings
4/07/2025 Hudson Institute Investment Holdings On Market sale $ 319.80
Ordinary fully paid shares 780 Hudson Institute Investment Holdings
7/07/2025 Hudson Institute Investment Holdings On Market sale $ 16,496.40
Ordinary fully paid shares 41,241 Hudson Institute Investment Holdings
7/07/2025 Hudson Institute Investment Holdings On Market sale $ 10,125.00
Ordinary fully paid shares 25,000 Hudson Institute Investment Holdings
7/07/2025 Hudson Institute Investment Holdings On Market sale $ 41.41
Ordinary fully paid shares 101 Hudson Institute Investment Holdings
23/07/2025 Hudson Institute Investment Holdings On Market sale $ 158.40
Ordinary fully paid shares 396 Hudson Institute Investment Holdings
24/07/2025 Hudson Institute Investment Holdings On Market sale $ 34,043.20
Ordinary fully paid shares 85,108 Hudson Institute Investment Holdings
25/07/2025 Hudson Institute Investment Holdings On Market sale $ 7,798.40
Ordinary fully paid shares 19,496 Hudson Institute Investment Holdings
30/07/2025 Hudson Institute Investment Holdings On Market sale $ 3,286.80
Ordinary fully paid shares 8,217 Hudson Institute Investment Holdings
31/07/2025 Hudson Institute Investment Holdings On Market sale $ 6,713.20
Ordinary fully paid shares 16,783 Hudson Institute Investment Holdings
31/07/2025 Hudson Institute Investment Holdings On Market sale $ 9,402.89
Ordinary fully paid shares 23,217 Hudson Institute Investment Holdings
29/08/2025 Hudson Institute Investment Holdings On Market sale $ 12,950.00
Ordinary fully paid shares 35,000 Hudson Institute Investment Holdings
8/09/2025 Hudson Institute Investment Holdings On Market sale $ 17,609.78
Ordinary fully paid shares 47,594 Hudson Institute Investment Holdings
8/09/2025 Hudson Institute Investment Holdings On Market sale $ 18,750.00
Ordinary fully paid shares 50,000 Hudson Institute Investment Holdings
10/09/2025 Hudson Institute Investment Holdings On Market sale $ 15,000.00
Ordinary fully paid shares 40,000 Hudson Institute Investment Holdings
9/09/2025 Hudson Institute Investment Holdings On Market sale $ 30,062.02
Ordinary fully paid shares 81,546 Hudson Institute Investment Holdings
10/09/2025 Hudson Institute Investment Holdings On Market sale $ 24,375.00
Ordinary fully paid shares 65,000 Hudson Institute Investment Holdings
10/09/2025 Hudson Institute Investment Holdings On Market sale $ 3,775.00
Ordinary fully paid shares 10,000 Hudson Institute Investment Holdings
10/09/2025 Hudson Institute Investment Holdings On Market sale $ 72,915.54
Ordinary fully paid shares 191,883 Hudson Institute Investment Holdings
10/09/2025 Hudson Institute Investment Holdings On Market sale $ 33,925.05
Ordinary fully paid shares 88,117 Hudson Institute Investment Holdings
11/09/2025 Hudson Institute Investment Holdings On Market sale $ 6,650.00
Ordinary fully paid shares 17,500 Hudson Institute Investment Holdings
11/09/2025 Hudson Institute Investment Holdings On Market sale $ 9,625.00
Ordinary fully paid shares 25,000 Hudson Institute Investment Holdings
12/09/2025 Hudson Institute Investment Holdings On Market sale $ 3,850.00
Ordinary fully paid shares 10,000 Hudson Institute Investment Holdings
12/09/2025 Hudson Institute Investment Holdings On Market sale $ 3,630.90
Ordinary fully paid shares 9,555 Hudson Institute Investment Holdings
12/09/2025 Hudson Institute Investment Holdings On Market sale $ 6,729.38
Ordinary fully paid shares 17,945 Hudson Institute Investment Holdings
$ 385,140.97
1,000,000
**Date of Change ** Person whose relevant interest changed Nature of Change Consideration Class of Securities Number of
Shares
Person's votes affected
Dilution from issue of shares
29/12/2025 Hudson Institute Investment Holdings under a thrid party placement $ -
Ordinary fully paid shares 6,500,000 Hudson Institute Investment Holdings
by Cleo Diagnostics Ltd

==> picture [74 x 50] intentionally omitted <==

05/01/2026

This is Annexure A of 3 pages referred to in form 605 Notice of ceasing to be a substantial holder